₹ 5,113.50
34.50 (0.68%)
A
Alkem Laboratories
₹ 5,113.50
Alkem Laboratories Share Price Today
Alkem Laboratories (ALKEM) share price is trading at ₹5,113.50 on the NSE as of October 30, 2026 at 03:50 PM, up by 0.68% from its previous close of ₹5,079.00. In todays trading session ALKEM reached a high of 5,134.50 and low of 5,030.00. The average traded price for today is 5,085.08. The 50 DMA stands at 5,222.04 and 200 DMA is at 5,443.50. Looking at intraday trend, the stock is moving sideways.
Stock Overview
- Symbol : ALKEM
- Open : ₹5,060.50
- Previous Close : ₹5,079.00
- Day's Range : ₹5,030.00 – ₹5,134.50
- 52-Week Range : ₹4,811.00 – ₹5,933.50
Get 20+ Chart Types, 180+ Indicators, 80+ Drawing Tools & Create Custom Indicators for FREE.
ALKEM Stock Performance
Markets Today
High
5,134.50
Low
5,030.00
Open at
5,060.50
Prev Close
5,079.00
Volumes
1,08,036
Avg Price
5,085.08
Lower Circuit
4,602.50
Upper Circuit
5,624.50
Last Traded Details
Quantity
10
Time
15:50:00
Price Movement
Historical Performance
3 M High
5,882.50
3 M Low
4,811.00
1 Yr High
5,933.50
1 Yr Low
4,811.00
3 Yr High
6,439.90
3 Yr Low
3,650.20
5 Yr High
6,439.90
5 Yr Low
2,828.00
1-Year Performance
ALKEM Pros and Cons
Gross Profit Margin climbs from 65.3% in Q1 FY26 to 67.9% in Q1 FY27 — confirming strong pricing power across the portfolio.
Market Capitalization grows from ₹590,457 Cr in Q1 FY26 to ₹665,894 Cr in Q1 FY27 — reflecting sustained investor confidence.
Net Cash increases from ₹48.7 Cr in Q1 FY26 to ₹57.64 Cr in Q1 FY27 — building a robust liquidity buffer for future investments.
Non-US Business Sales expand from ₹3,556 Cr in Q1 FY26 to ₹4,785 Cr in Q1 FY27 — driving steady international diversification.
Institutional Shareholding rises from 30.9% in Q1 FY26 to 33.1% in Q1 FY27 — signaling growing fund trust in long-term execution.
PAT Margin falls from 19.7% in Q1 FY26 to 13.9% in Q1 FY27 — indicating ongoing profit margin pressure despite revenue recovery.
Promoter Shareholding declines from 53.0% in Q1 FY26 to 49.7% in Q1 FY27 — reflecting gradual stake dilution over the period.
US Business Sales cool from ₹7,681 Cr in Q4 FY26 to ₹7,439 Cr in Q1 FY27 — signaling a temporary normalization in key export markets.
Respiratory Market Share slips from 1.6% in Q2 FY26 to 1.5% in Q1 FY27 — indicating minor competitive erosion in the segment.
ANDA Tentative Approvals drop from 2 in Q1 FY26 to 1 in Q1 FY27 — pointing to a slower regulatory pipeline pace for new launches.
ALKEM Analyst Rating
Buy
Analysts have suggested that investors can
Buy this Stock
- By Refinitiv from 20 analysts
Buy
60%
Hold
30%
Sell
10%
Get forecast for Price, ROA & ROE based on analyst ratings.
ALKEM Share Price History
ALKEM Fundamentals
Company Valuation
Market Cap (₹ Cr.)
61,140
PE Ratio
27.40
PB Ratio
4.37
Dividend Yield
1.04%
ROE
16.40%
ROCE
18.84%
Book Value (₹)
1,155.87
Face Value (₹)
2.00
Analyse ALKEM with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 51.20% | 51.20% | 51.20% | 49.70% | 49.70% |
| Domestic Institutional Investors (DII) | 21.93% | 21.54% | 21.40% | 22.63% | 22.82% |
| Foreign Institutional Investors (FII) | 9.48% | 9.97% | 10.16% | 10.42% | 10.32% |
| Public Investors | 17.18% | 17.09% | 17.06% | 17.04% | 16.93% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
Alkem Laboratories Return Calculator
Note: Past profits do not guarantee future returns.
ALKEM Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
ALKEM Technicals
Moving Averages
Technical Indicators
Summary of Technical Indicators for ALKEM
Margin on ALKEM
*Calculated on NSE. Applicable on all exchanges. Margins are subject to change from time to time or may be withdrawn under volatile market conditions. Intraday Orders are square-off automatically at 03:19 pm on NSE / BSE or on hitting 80% of margin utilisation (whichever earlier).
ALKEM Financials Summary
In Crores
ALKEM Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Corporate Actions
The above dates are ex-dates.
Check ALKEM latest Company Filings, Investor Presentation & Conference Call details.
ALKEM Revenue Growth
All values are in Crores
Revenue
Profit
Loss
ALKEM Options Snapshot
ALKEM Futures Snapshot
Use from 12+ Pre-built Strategies or Build Your Own to trade ALKEM FnO contracts.
ALKEM Similar Stocks
FAQs on ALKEM
What is the share price of Alkem Laboratories?
What is the 52W high and 52W low of Alkem Laboratories?
What is the return on Alkem Laboratories share?
- Past 1 year: -7.62%
- Past 3 years: 39.14%
- Past 5 years: 41.62%
What is the PE and PB Ratio of Alkem Laboratories?
What is the EPS of Alkem Laboratories?
What is the shareholding pattern of Alkem Laboratories?
- DIIs - 22.82%
- FII - 10.32%
- Promoters - 49.70%
- Public Investors 16.93%
- Goverenment - 0.00%
How to buy Alkem Laboratories shares online?
How to buy Alkem Laboratories shares on Dhan?
- Download the Dhan App to Open a Demat Account
- Navigate to the “Money Tab”
- Add money to your account
- Search for Alkem Laboratories share
- Tap on “Buy”
Option Chain